Ji Hoon Shin

Plain English
This study looked at the impact of central nervous system (CNS) cancers in the United States from 1990 to 2021, analyzing data from various sources. In 2021, there were about 31,780 new cases of CNS cancer, with a mortality rate of 4.1 per 100,000 people, and while the number of cases stayed the same over the years, deaths and years lost to disability due to these cancers dropped by about 8% and 15%, respectively. The research highlights that certain states like Mississippi and West Virginia had consistently high rates of CNS cancer, and men were more heavily affected than women; this information is key for guiding health policies and resource allocation. Who this helps: This helps patients, healthcare providers, and policymakers by identifying where support and resources are most needed.

Plain English
This study looked at the number of children and teens with epilepsy around the world from 1990 to 2021, finding there were 18.15 million cases in 2021. While the death rate from a type of epilepsy not caused by other conditions (idiopathic epilepsy) has dropped, cases of epilepsy linked to other health issues (secondary epilepsy) increased by 16.14% over the years, especially in poorer regions. This situation matters because it highlights ongoing challenges in treating and supporting young people with epilepsy, especially in areas with limited healthcare resources. Who this helps: This benefits children and adolescents with epilepsy, their families, and healthcare providers.

Plain English
This study looked at how common a harmful germ called Listeria monocytogenes is in pork produced in Korea, along with how resistant it is to treatment and its genetic characteristics. The researchers found Listeria in 19% of retail meat samples, mainly from processing and distribution rather than from farms or slaughterhouses. They identified several specific types of the germ, including one that is more dangerous and has shown up in past outbreaks, which highlights the importance of improving hygiene and monitoring in the meat industry to prevent foodborne illnesses. Who this helps: This research benefits food safety regulators, meat producers, and consumers.

Plain English
This study looked at the effects of two types of diabetes medications—GLP-1s and DPP-4s—on the risk of developing dementia in patients who need hemodialysis. The researchers found that among 15,121 patients, those taking GLP-1s had a lower risk of being diagnosed with dementia (10.2%) compared to those on DPP-4s (11.2%), with a specific reduction in risk shown by a ratio of 0.82. However, patients on GLP-1s had a slightly higher risk of ketoacidosis, a serious condition. Who this helps: This information is valuable for doctors treating diabetes patients who require hemodialysis, helping them make informed medication choices.

Plain English
This study looked at how patients in Stockholm with newly detected albuminuria—an early sign of kidney damage—were managed by doctors. Out of 215,035 adults identified, 90% had moderate albuminuria, but only 46% were retested within a year, and a mere 28% were referred to a kidney specialist. This is important because many patients, especially those with severe cases that need urgent attention, were not receiving the follow-up care they needed, which could lead to worse kidney problems later on. Who this helps: This helps patients at risk of kidney disease and their healthcare providers.

Plain English
This study looked at two types of diabetes medications—SGLT2 inhibitors and GLP-1 receptor agonists—to see how well they prevent kidney failure in people with type 2 diabetes. Researchers found that SGLT2 inhibitors lower the risk of kidney failure more effectively than GLP-1 receptor agonists, with a 18% reduced risk, and that combining both medications might be particularly beneficial for high-risk patients, reducing the risk by 46%. This is important because preventing kidney failure can significantly improve the health and quality of life for people with diabetes. Who this helps: This helps patients with type 2 diabetes, especially those at high risk of kidney problems.

Plain English
This study looked at how often older adults with type 2 diabetes are prescribed a specific medication called SGLT2 inhibitors, which can help with heart and kidney health. Researchers found that only 15.2% of all patients and just 25.5% of those eligible for the medication received a prescription. The prescription rates dropped significantly with age; for example, only 13.7% of those aged 80 and over were prescribed the drug, compared to 37.6% of those under 60. Who this helps: This benefits patients with type 2 diabetes, especially older women who were prescribed the medication at lower rates than men.

Plain English
This study looked at how adding a flower extract from Abelmoschus manihot to chicken feed affects chicken growth and health. Chickens that got a diet with 0.04% of the flower extract gained weight more efficiently and had better intestinal health than those that didn't receive the extract. Specifically, those on the higher dose had a significant improvement in weight gain and lower movement issues. Who this helps: This benefits poultry farmers and the broiler chicken industry.

Plain English
This study compared two ways of measuring the impact of gastric cancer in Korea and Japan between 2008 and 2018. The Korean National Burden of Disease (KNBD) study showed that while the number of years lost due to cancer decreased, the number of years people lived with disabilities increased significantly, indicating that more patients were surviving but facing ongoing health issues. In contrast, global estimates from GBD showed little change in disability levels, raising questions about their accuracy in representing the reality of cancer survivors' experiences. Who this helps: This research helps policymakers and healthcare planners understand the true impact of cancer on patients' lives.

Plain English
This study explored the experiences of people who have attempted suicide, gathering insights from both individuals with lived experience and academic researchers. It revealed that these individuals often feel overwhelmed by hopelessness and despair, face stigma, and encounter barriers to accessing mental health care. Understanding their complex experiences is crucial for improving support and care, as it emphasizes the need for sensitivity and accessibility in mental health services. Who this helps: This helps patients dealing with suicidal thoughts and their healthcare providers.

Plain English
This study looked at the use of drugs like amphetamines, cannabis, cocaine, and opioids across 204 countries from 1990 to 2023. It found that issues related to drug use disorders have significantly increased, with the number of people affected rising from 169.3 cases per 100,000 in 1990 to 212.0 in 2023. In 2023, cannabis use disorder was most common, affecting 270.8 per 100,000 people, followed by opioid use disorder at 205.9 per 100,000, which nearly doubled since 1990. This increase is particularly notable in high-income countries like the USA, highlighting the need for better policies to address these growing health challenges. Who this helps: This research benefits public health officials, policymakers, and communities affected by drug use.

Plain English
This research looked at how a new type of surgery, called biportal endoscopic surgery, can treat spinal epidural abscesses, which are serious infections in the spinal area. The study involved 15 patients treated between May 2020 and June 2023, and it found that more than half (53%) had infections identified during surgery, with 73% of patients overall showing positive results for pathogens. After one year, patients reported significant pain relief and improved function, with no need for additional surgery. Who this helps: This research benefits patients suffering from spinal epidural abscesses by providing a potentially safer surgical option.

Plain English
This study examined a new way to create liver cells using a combination of chemicals. Researchers found that blocking a process called autophagy helped these liver cells grow more efficiently. Specifically, when autophagy was suppressed, the cells proliferated better during their creation, which could lead to new treatments for severe liver diseases. Who this helps: This benefits patients with severe liver diseases by potentially providing new therapeutic options.

Plain English
This study looked at how a specific measure of tumor DNA in the blood, called maximum somatic allele frequency (MSAF), can help predict outcomes for patients with metastatic gastric cancer. They found that patients with high MSAF (over 12.31%) lived around 10 months on average, compared to about 17.6 months for those with low MSAF. Understanding MSAF could improve how doctors assess patient risk and tailor treatment plans for better outcomes. Who this helps: This helps patients with metastatic gastric cancer and their doctors.

Plain English
This study focused on the psychological struggles faced by family caregivers of patients who have been in intensive care units (ICUs). It found that many caregivers experience high levels of anxiety, depression, and post-traumatic stress, with some symptoms lasting long after their loved ones leave the hospital. Addressing these issues is important because it can lead to better support and mental health for caregivers, ultimately helping them cope during very stressful times. Who this helps: This helps family caregivers of ICU patients.

Plain English
Researchers studied an outbreak of a drug-resistant bacteria called KPC-2-producing Enterobacterales in a South Korean hospital between July and September 2019. They found a total of 42 cases, with 33 linked to the hospital, and discovered that hidden transmission was occurring even before the outbreak was recognized. This highlights the importance of active monitoring to catch such infections early and shows that this bacteria can spread covertly, which can make controlling outbreaks much harder. Who this helps: Patients and healthcare providers in hospitals.

Plain English
This study examined gastric cancer trends from 1990 to 2021 across all U.S. states, revealing significant differences based on geography, race, and socioeconomic status. Although the overall rates of gastric cancer decreased, states with large immigrant and low-income populations, like Mississippi and New Mexico, showed much higher rates, with Asian populations experiencing about four times the incidence compared to Hispanic groups. The research found that factors like income and education accounted for 22% to 31% of the differences in gastric cancer rates between racial and ethnic groups, highlighting the importance of addressing these socioeconomic issues to reduce health disparities. Who this helps: This research benefits patients at higher risk for gastric cancer, healthcare providers, and policymakers focused on equitable healthcare access and prevention strategies.

Plain English
This study looked at the role of a protein called PD-L1 in lung cancer, specifically how it helps tumors grow and spread by promoting a process called autophagy. Researchers found that higher levels of PD-L1 in lung cancer cells were linked to more aggressive cancer behavior, such as faster growth and spread; when they removed PD-L1, tumor growth decreased significantly. Understanding this link is important because it suggests that targeting PD-L1 could be an effective way to treat lung cancer by not only fighting the immune system but also directly affecting the cancer cells themselves. Who this helps: This helps patients with lung cancer.

Plain English
This study looked at how well avacopan, a drug for treating a severe kidney disease called ANCA-associated vasculitis (AAV), works in real-world situations beyond clinical trials. The findings showed that 89% of patients achieved remission within six months of starting the medication, and 14% experienced serious infections, which is similar to results from earlier trials. Understanding these results is important because they confirm that avacopan is both effective and relatively safe in diverse groups of patients, but they also highlight a need for monitoring liver health, especially in Japanese patients. Who this helps: This benefits patients with ANCA-associated vasculitis and their healthcare providers.

Plain English
This study looked at how to improve the care of people with dyspepsia, a common stomach issue, to prevent gastric cancer, especially in high-risk groups in the U.S. Researchers found that tailoring treatment based on factors like ancestry and family history could help identify and treat those at greater risk earlier. This is important because earlier detection and treatment can save lives and reduce the number of preventable deaths from gastric cancer. Who this helps: This helps patients with dyspepsia, particularly those from high-risk backgrounds.

Plain English
This study looked at patients with rare neuroendocrine tumors in the gastrointestinal system and pancreas who were treated with a drug called everolimus. Among 28 patients, those with changes in the PI3K/AKT/mTOR pathway saw a significant improvement, with 48% showing an objective response to the treatment compared to only 14% in patients without those changes. This matters because identifying which patients will benefit from everolimus could lead to better-targeted treatments and improved outcomes. Who this helps: This helps patients with gastrointestinal and pancreatic neuroendocrine tumors.

Plain English
This study looked at how the size of clinical trials for COVID-19 treatments affects their results. Researchers found that smaller trials often suggested better treatment effects that were less stable and more uncertain. Specifically, they analyzed 221 trials and found that small trials often produced more extreme results and less consistent data compared to larger trials, which provided more reliable and trustworthy information. This is important because relying on smaller trials can lead to misunderstandings about how effective treatments really are. Who this helps: This helps doctors and researchers make better treatment decisions for COVID-19 patients.

Plain English
This study looked at how to improve the process of creating umbrella reviews, which are summaries of multiple research studies that examine health patterns and trends. The researchers found that existing guidance is limited, with only eight useful documents identified out of nearly 4,500 examined. This is important because clear guidelines can help researchers report findings better, leading to a more accurate understanding of public health issues. Who this helps: This helps researchers and public health officials.

Plain English
Researchers studied the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on heart and kidney health in nearly 175,000 people with type 1 diabetes. They found that using GLP-1RAs reduced the risk of major heart problems from 5.0% to 4.3% over five years, and the risk of severe kidney disease from 1.9% to 1.6%. This matters because it shows that GLP-1RAs can help protect against serious health issues without increasing the risk of dangerous conditions like diabetic ketoacidosis or severe low blood sugar. Who this helps: This benefits patients with type 1 diabetes.

Plain English
This research focused on a specific genetic deletion found in certain cancers, particularly at chromosome 9p21. The study examined 579 tumor samples and found that this deletion occurred in just 2.4% of the cases, being more common in sarcomas, pancreatic cancers, and urothelial carcinomas. Understanding this genetic pattern is important because it helps identify patients who may respond well to new targeted therapies. Who this helps: Patients with specific types of solid tumors that may benefit from targeted treatments.

Plain English
This large multinational study surveyed over 6,000 children aged 6 to 13 in 12 countries across the COVID-19 pandemic and found that wellbeing dropped and mental health symptoms increased, though both returned close to pre-pandemic levels after two years. Depression screening rates roughly doubled during the pandemic, with girls, children with pre-existing health conditions, and those affected by school closures hit hardest. Family contact, outdoor play, and time with pets were the most commonly used coping strategies.

Plain English
This study looked at a serious condition called a bronchial artery-bronchus fistula, which can cause severe bleeding from the lungs. An 80-year-old man with a history of lung problems experienced heavy bleeding and underwent two embolizations, but when those didn't work, doctors performed emergency surgery to remove part of his lung. He had a complication after surgery but was able to go home a month later after receiving treatment. Who this helps: This helps patients with severe lung bleeding and doctors treating these complex cases.

Plain English
This study looked at how well combining chemotherapy with immune checkpoint inhibitors (ICIs) works for patients with non-small cell lung cancer (NSCLC) who have specific gene changes, excluding the more common mutations. Researchers found that patients receiving the combination treatment had a median progression-free survival of 8.0 months, compared to 6.4 months for those who only had chemotherapy. Importantly, patients with the METex14 gene change showed the best outcomes, with a progression-free survival of 17.1 months, and the effectiveness of the treatment improved with higher PD-L1 expression levels. Who this helps: This research benefits NSCLC patients with actionable gene alterations, providing potential new treatment options.

Plain English
This study looked at how well randomized controlled trials (RCTs) for a type of vasculitis known as anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) followed reporting standards. Researchers found that while the overall adherence to reporting guidelines was good at 83%, many important details were missing, with only 10% of trials mentioning the required checklist. Improving how these trials are reported matters because clear and complete information helps doctors make better treatment decisions. Who this helps: This helps doctors and researchers working with patients suffering from AAV.

Plain English
This study looked at how well research on stem cells for Parkinson's disease reports its methods and findings, especially in relation to established guidelines. Out of 90 studies analyzed, none reported key information like sample size calculations or details on any potential negative effects, and only about 20% included any strategies to improve research quality. This matters because better reporting can lead to more reliable and reproducible results, ultimately accelerating progress in treatment development. Who this helps: This helps researchers and clinicians working on Parkinson's disease.

Plain English
This study looked at how sleeping in on weekends affects obesity among working adults in Korea. Researchers found that workers who caught up on sleep over the weekend had a higher chance of being obese, with a 21% increased risk for general obesity and an 18% increased risk for abdominal fat compared to those who got enough sleep during the week. Those who didn't get enough sleep all week had even higher risks, with a 23% and 33% increase for general and abdominal obesity, respectively. This matters because it highlights the importance of consistent, good sleep for preventing obesity, not just making up for lost sleep on the weekends. Who this helps: This helps working adults and healthcare providers understand the link between sleep and obesity.

Plain English
This paper corrects earlier findings about how not having enough food affects mental health in young people. It shows that adolescents who experience food insecurity are more likely to struggle with depression, anxiety, and stress, with nearly 30% reporting high levels of depression. This matters because it highlights the importance of addressing food access to improve mental well-being in teens. Who this helps: This helps teenagers dealing with food insecurity and those who support their mental health.

Plain English
Researchers studied how to better predict the rapid growth of abdominal aortic aneurysms (AAAs) using advanced artificial intelligence (AI). They developed a deep learning model that combined CT images and clinical data from 561 patients, achieving an accuracy of 75.8% in predicting rapid aneurysm progression, which is significantly better than traditional methods. This is important because accurately identifying patients at risk can help with timely medical interventions to prevent ruptures. Who this helps: This benefits patients with abdominal aortic aneurysms and their doctors.

Plain English
This study looked at how a herbal extract called HemoHIM G affects the immune system in mice that had their immune function weakened by a drug called cyclophosphamide. The researchers found that HemoHIM G helped the mice regain weight, increased their white blood cell counts, and improved the activity of specific immune cells (Natural Killer cells), suggesting it boosts overall immunity. These findings are significant because they indicate that HemoHIM G may be a beneficial supplement for supporting immune health. Who this helps: This helps patients who need immune support, especially those undergoing treatments that weaken the immune system.

Plain English
This study looked at a protein called TXNIP and its role in lung cancer. Researchers found that TXNIP could slow down lung cancer growth by blocking certain signals that promote tumor development. In lung cancer patients, lower levels of TXNIP were associated with a higher risk of the cancer spreading and worse survival rates. Who this helps: This helps patients with lung cancer by providing insights into potential new treatment pathways.

Plain English
This study looked at the role of a protein called PYCR1 in non-small-cell lung cancer (NSCLC), which is a serious type of lung cancer. Researchers found that PYCR1 is increased in lung cancer tissues and helps cancer cells grow and spread; when they removed PYCR1 from lung cancer cells, those cells grew slower and formed fewer tumors. Targeting PYCR1 with a specific drug significantly reduced tumor growth, suggesting that blocking PYCR1 could be an effective treatment strategy for lung cancer. Who this helps: This helps patients with non-small-cell lung cancer and their doctors in developing new treatment options.

Plain English
This study looked at whether a home training program could help people with spinal cord injuries improve their health and fitness. Fifteen participants completed a six-week resistance training program at home, which led to increased lean body mass and healthier cholesterol levels. They also showed significant improvements in their physical fitness, such as better endurance and strength. Who this helps: This benefits individuals with spinal cord injuries seeking to enhance their physical health and fitness at home.

Plain English
This study looked at various treatments for attention deficit/hyperactivity disorder (ADHD) across different age groups to see how effective they are in reducing symptoms and their side effects. Researchers reviewed 115 relevant studies and found that medications like methylphenidate and atomoxetine, as well as cognitive behavioral therapy, significantly reduced ADHD symptoms in both children and adults, but these treatments also had noticeable side effects. An online platform was created to help patients and doctors make informed choices about ADHD treatments based on strong evidence. Who this helps: This benefits patients with ADHD and their healthcare providers.

Plain English
This study looked at the effectiveness of a cancer treatment combining nivolumab and chemotherapy in patients with advanced gastric cancer (AGC) based on their levels of a protein called PD-L1. Among 143 patients, those with a PD-L1 score of 5 or higher had better outcomes, with a progression-free survival (PFS) of 10 months compared to 6.8 months for those with lower scores. Although the overall survival rates were 26.2 months for the higher PD-L1 group and 18.8 months for the lower group, the difference wasn't statistically significant, indicating that patients with any level of PD-L1 might still benefit from this treatment. Who this helps: This research helps advanced gastric cancer patients and their doctors by providing insights into effective treatment options.

Plain English
This study investigated the use of quick-dissolving gelatin sponge particles to stop bleeding in the lower gastrointestinal tract, especially when other treatments failed. Among 29 patients treated, 100% successfully had their blood vessels blocked, and 76% saw their bleeding stop without severe complications, while 7 patients experienced further bleeding within a week. The findings show that this method is both effective and safe, with very few minor complications. Who this helps: This helps patients suffering from acute lower gastrointestinal bleeding.

Plain English
This study focused on developing a new method to quickly identify antiviral substances using a safer virus as a stand-in for more harmful ones. Researchers screened over 44,000 chemical compounds and more than 8,000 plant extracts, narrowing it down to 140 potential candidates, with 8 compounds and 5 plant extracts chosen for further testing; one compound stood out with an impressive selectivity index of 1046, showing strong antiviral activity. This research is important because it helps find effective treatments for viral infections, which is critical as drug resistance increases. Who this helps: This benefits patients fighting viral infections, as well as doctors seeking effective treatments.

Plain English
This study looked at how well a treatment combining the drug nivolumab and chemotherapy works for stomach cancer patients with a low combined positive score (CPS) ranging from 1 to 4. Out of 336 patients treated, 63 had a low CPS; 42% responded positively to the treatment, with 2% showing complete recovery. The average time before the cancer got worse was about 5.8 months, and patients lived for about 15 months after starting treatment, though 92% experienced some side effects. Who this helps: This research is beneficial for stomach cancer patients with low CPS, their doctors, and treatment planners.

Plain English
This study looked at how using electronic cigarettes affects sleep quality in adults in Korea. It found that 34.2% of participants had poor sleep, and those who only used e-cigarettes had a 73% higher chance of poor sleep compared to non-smokers. This matters because it highlights that e-cigarette use is linked to sleep problems, which could impact overall health and well-being. Who this helps: This helps patients who use e-cigarettes and may be struggling with sleep issues.

Plain English
This study examined the role of a protein called USP11 in the progression of colorectal cancer (CRC). Researchers found that USP11 was significantly higher in tumor tissues from 35 patients, which was linked to poorer survival rates. When they manipulated levels of USP11 in lab-grown cancer cells, they discovered that higher USP11 increased tumor growth and spread, while reducing it led to less tumor activity. Targeting USP11 with a drug called mitoxantrone effectively slowed tumor growth in tests, highlighting its potential as a treatment target for CRC. Who this helps: This benefits patients with colorectal cancer and their doctors by offering a potential new treatment strategy.

Plain English
This research studied the genetic factors related to recurrent pregnancy loss (RPL) in 765 women, comparing 388 who experienced RPL to 377 healthy women. They found that a specific genetic variation (the rs2240879 CC genotype) increased the risk of RPL by 2.8%, while the combination of other genetic variations also indicated heightened risk levels, particularly a combination linked to a less than 0.1% probability. Understanding these genetic links is essential as it may help identify women at higher risk for RPL, potentially guiding better clinical support and interventions. Who this helps: This helps patients facing recurrent pregnancy loss and their doctors.

Plain English
This study looked at how effective a drug combination called atezolizumab plus bevacizumab (Atezo-Bev) is compared to traditional local treatments for advanced liver cancer that has spread to blood vessels. Researchers analyzed data from 475 patients and found that while the average survival time was slightly longer with traditional treatments (10.8 months) compared to Atezo-Bev (9.3 months), the time without the cancer worsening was better with Atezo-Bev (6 months versus 4.1 months). This information is important because it shows that Atezo-Bev could be a good first option for managing this type of advanced liver cancer, alongside existing treatments. Who this helps: This helps patients with advanced liver cancer, especially those with vascular invasion.